The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns, use of healthcare resources, and clinical characteristics of patients with castration-resistant prostate cancer (mCRPC) in Colombia: Preliminary analysis from ProColombia RC study.
 
Ray Manneh
Leadership - Sociedad de Oncología y Hematología del Cesar (I)
Honoraria - Amgen; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Tecnofarma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche; Sanofi; Tecnofarma
Speakers' Bureau - Asociación Colombiana de Hematoligía y Oncología (ACHO); San Jorge Foundation
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Merck Sharp & Dohme; Novartis; Pfizer
Travel, Accommodations, Expenses - Bayer; Merck Sharp & Dohme; Pfizer; Roche/Genentech
 
Camila Lema
No Relationships to Disclose
 
Beatriz Preciado
Leadership - Clínica de Oncología Astorga (I)
Stock and Other Ownership Interests - Clínica de Oncología Astorga (I)
Honoraria - Clíncia de Oncología Astorga, Suramericana, Coomeva Medicina Prepagada, Colsanitas, Medplus; Clíncia de Oncología Astorga, Suramericana, Coomeva Medicina Prepagada, Colsanitas, Medplus (I)
Consulting or Advisory Role - Tecnofarma, GSK, Biotoscana / Knight, Bayer, Janssen, BMS, Boehringer Ingelheim, Aztra Zeneca, MSD, Pfizer, ROCHE, AMGEN, Eli-Lilly (I)
Speakers' Bureau - Tecnofarma, AZ, GSK, Biotoscana / Knight, BMS, Bayer, Janssen, Lilly, Pfizer, ROCHE, MSD, AMGEN (I)
Research Funding - BMS, ROCHE, Pfizer, MSD (I)
Travel, Accommodations, Expenses - MSD, ROCHE, Pfizer; MSD, ROCHE, Pfizer (I)
 
Rafael Quintana
Employment - Merck
Stock and Other Ownership Interests - Merck
Honoraria - Merck
 
Mauricio Lema
Leadership - Clínica de Oncología Astorga
Stock and Other Ownership Interests - Clínica de Oncología Astorga
Honoraria - líncia de Oncología Astorga, Suramericana, Coomeva Medicina Prepagada, Colsanitas, Medplus
Consulting or Advisory Role - Tecnofarma, GSK, Biotoscana / Knight, Bayer, Janssen, BMS, Boehringer Ingelheim, Aztra Zeneca, MSD, Pfizer, ROCHE, AMGEN, Eli-Lilly
Speakers' Bureau - Tecnofarma, AZ, GSK, Biotoscana / Knight, BMS, Bayer, Janssen, Lilly, Pfizer, ROCHE, MSD, AMGEN
Research Funding - BMS, ROCHE, Pfizer, MSD
Travel, Accommodations, Expenses - Tecnofarma, AZ, GSK, Biotoscana / Knight, BMS, Bayer, Janssen, Lilly, Pfizer, ROCHE, MSD, AMGEN
 
Emilio Pérez
No Relationships to Disclose
 
Mateo Pineda
No Relationships to Disclose
 
Ivan Bustillo
No Relationships to Disclose
 
Sebastian Saleh
No Relationships to Disclose
 
Ana Garcia
Speakers' Bureau - Janssen, IPSEN, Astellas
Research Funding - MSD
Travel, Accommodations, Expenses - Janssen, IPSEN, Adium
 
Maycos Zapata Muñoz
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex,AstraZeneca, Amgen, Lilly, Janssen Oncology, MSD Oncology, Merck Serono, Novartis AstraZeneca
Speakers' Bureau - Amgen AstraZeneca, Bristol-Myers Squibb/Medarex, Lilly, ,Janssen Oncology, MSD Oncology, Merck Serono, Novartis, Roche
Research Funding - Roche, MSD Oncology (Inst)
Travel, Accommodations, Expenses - Janssen Oncology, MSD Oncology, Roche, Merck Serono, AstraZeneca
 
Laura Bernal
Stock and Other Ownership Interests - Idime
Honoraria - Janssen, Bayer, Bristol-Mayers-Squibb, MSD, AstraZeneca, Pfizer, Tecnofarma, Novartis, Ipsen, Astellas Pharma
Consulting or Advisory Role - Janssen, Bayer, Ipsen, Pfizer, AstraZeneca, MSD
Speakers' Bureau - Janssen, Bayer, MSD, AstraZeneca, Bristol-Mayers-Squibb, Ipsen
Research Funding - MSD, GlaxoSmithKline
Travel, Accommodations, Expenses - Bayer, Janssen, MSD, AstraZeneca, Amgen, Pfizer